ACADIA Pharmaceuticals, Inc. (ACAD)
18.74
+0.60
(+3.31%)
USD |
NASDAQ |
Nov 13, 16:00
18.75
+0.01
(+0.05%)
After-Hours: 19:59
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 0.305 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.305 |
| June 30, 2026 | 0.1822 |
| March 31, 2026 | 0.0211 |
| December 31, 2025 | 1.596 |
| September 30, 2025 | 0.4206 |
| June 30, 2025 | 0.1581 |
| March 31, 2025 | 0.1132 |
| December 31, 2024 | 0.8623 |
| September 30, 2024 | 0.1972 |
| June 30, 2024 | 0.2009 |
| March 31, 2024 | 0.0994 |
| December 31, 2023 | 0.275 |
| September 30, 2023 | -0.3968 |
| June 30, 2023 | 0.0068 |
| March 31, 2023 | -0.2651 |
| December 31, 2022 | -0.2576 |
| September 30, 2022 | -0.1679 |
| June 30, 2022 | -0.2104 |
| March 31, 2022 | -0.7012 |
| December 31, 2021 | -0.2679 |
| September 30, 2021 | -0.09 |
| June 30, 2021 | -0.2735 |
| March 31, 2021 | -0.4153 |
| December 31, 2020 | -0.4192 |
| September 30, 2020 | -0.5354 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.2692 |
| March 31, 2020 | -0.5666 |
| December 31, 2019 | -0.3433 |
| September 30, 2019 | -0.2877 |
| June 30, 2019 | -0.3807 |
| March 31, 2019 | -0.5925 |
| December 31, 2018 | -0.4976 |
| September 30, 2018 | -0.4971 |
| June 30, 2018 | -0.51 |
| March 31, 2018 | -0.44 |
| December 31, 2017 | -0.55 |
| September 30, 2017 | -0.53 |
| June 30, 2017 | -0.55 |
| March 31, 2017 | -0.72 |
| December 31, 2016 | -0.65 |
| September 30, 2016 | -0.61 |
| June 30, 2016 | -0.63 |
| March 31, 2016 | -0.45 |
| December 31, 2015 | -0.45 |
| September 30, 2015 | -0.39 |
| June 30, 2015 | -0.39 |
| March 31, 2015 | -0.40 |
| December 31, 2014 | -0.28 |
| September 30, 2014 | -0.25 |
| June 30, 2014 | -0.22 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.6617 |
| Arcturus Therapeutics Holdings, Inc. | -0.2607 |
| ADMA Biologics, Inc. | 0.2209 |
| Immunic, Inc. | -0.8021 |
| Viking Therapeutics, Inc. | -1.552 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.52M |
| Revenue (Quarterly) | 342.29M |
| Total Expenses (Quarterly) | 288.77M |
| Enterprise Value | 2.230B |
| Gross Profit Margin (Quarterly) | 89.75% |
| Profit Margin (Quarterly) | 15.64% |
| Earnings Yield | 11.23% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 11.23 |